Abstract
Sepsis is associated with up to half of all in-hospital deaths. The administration of intravenous (IV) hydrocortisone, thiamine, and vitamin C has been suggested to improve mortality rates in patients with septic shock compared to those who received hydrocortisone alone, but the number of patients studied and the methods of previous studies have been scrutinized. The authors of this multi-center, randomized control trial aimed to determine if there is a significant difference in mortality and vasopressor requirements in patients with septic shock between hydrocortisone monotherapy and hydrocortisone therapy plus the addition of intravenous vitamin C and thiamine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
